The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new oral antibiotic for the treatment of uncomplicated urinary tract infections (UTIs) – the first of its kind in the UK for nearly three decades. Gepotidacin (Blujepa), suitable for females aged 12 years and over who weigh at least 40kg, targets and blocks two The post MHRA approves UK’s first new UTI antibiotic in nearly 30 years appeared first on Pulse Today.